Semaglutide vs. Tirzepatide: Which Is Better?

If you're comparing weight-loss injections, two names keep coming up: semaglutide and tirzepatide. Both are weekly GLP-1 medications, and both require a prescription. Both also appear across nearly every online weight loss program, including HermanRX's own Semaglutide + B12 and Tirzepatide + B12 treatment options.

So which one should you choose? In short: tirzepatide tends to produce greater average weight loss because it acts on two hormone receptors instead of one. Semaglutide, meanwhile, is the more established option, with a stronger long-term cardiovascular safety record and a slightly lower monthly price. After reviewing your health information and discussing your goals, your provider can recommend the option that best fits your individual needs.

Your provider will recommend the option that best fits your health needs. Here's exactly how the two compare, so you know what to expect before your assessment.

What Is Semaglutide?

How Semaglutide Works

Semaglutide is a GLP-1 receptor agonist, the same active ingredient found in Ozempic and Wegovy. It functions by acting like a naturally occurring gut hormone that is released after meals.  That hormone signals your brain that you're full, slows how quickly food leaves your stomach, and helps regulate blood sugar. In a compounded weekly injection, semaglutide is often paired with vitamin B12 to help support energy levels during a calorie deficit.

The Appetite-Suppressing Effect

Semaglutide's appetite-suppressing effect comes largely from signalling in the hypothalamus, the region of the brain that governs hunger and fullness cues. Many patients describe this as a quieting of "food noise." That's the near-constant background chatter about food and cravings that makes sticking to a lower-calorie diet difficult. By reinforcing "I'm full" signals and slowing gastric emptying, semaglutide helps reduce overall calorie intake without requiring constant willpower against hunger.

What Is Tirzepatide?

How Tirzepatide Works

Tirzepatide is a newer, dual-action medication and the same active ingredient in Mounjaro and Zepbound. Rather than acting on a single receptor, it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. That added pathway is why tirzepatide is generally associated with more pronounced appetite suppression and quieter food noise. On average, it also produces a greater percentage of body weight lost compared with semaglutide alone.

A Dual-Hormone Approach

Think of it as two complementary signals instead of one. GLP-1 helps regulate appetite and gastric emptying, while GIP contributes to insulin sensitivity and metabolic efficiency. Some early research suggests GIP activity may also help offset some of the nausea associated with GLP-1 alone. That effect has mainly been observed in preclinical studies, though, rather than confirmed in large human trials.

Semaglutide vs. Tirzepatide: Key Differences at a Glance

*Individual results vary and are not guaranteed. Figures reflect commonly reported clinical trial and observational ranges, not a promise of outcome.

Which One Leads to More Weight Loss?

Tirzepatide leads to more weight loss. Because it works on two receptors instead of one, most patients see a somewhat larger average reduction in body weight over the same treatment period. This isn't just a theoretical difference; it has been tested directly.

The Head-to-Head Trial Data

The SURMOUNT-5 trial compared the two medications head-to-head in adults with obesity over 72 weeks. It found tirzepatide produced meaningfully greater average weight loss than semaglutide (20.2% vs. 13.7%).

Real-World Results vs. Clinical Trials

It's worth separating clinical-trial results from real-world results, since they often differ. A large observational study followed more than 20,000 tirzepatide patients outside of a trial setting. It found an average weight loss closer to 11% at six months, with slower dose titration than in formal trials. That doesn't mean tirzepatide is less effective. It reflects real-life pacing, adherence, and individual responses, making it a more realistic benchmark than trial-only figures.

Semaglutide's Cardiovascular Advantage

Tirzepatide's advantage on the scale isn't the whole picture, though. Semaglutide has a meaningfully longer cardiovascular safety record. The SELECT trial followed over 17,000 adults with overweight or obesity and established heart disease for more than three years. It found that semaglutide reduced major adverse cardiac events, cardiovascular death, heart attack, or stroke by 20%. Tirzepatide does not yet have an equivalent completed cardiovascular outcomes trial in a weight-loss population, though one is currently underway.

"Neither medication wins on every measure. Tirzepatide tends to produce greater weight loss, but semaglutide currently has more long-term cardiovascular data. That trade-off is exactly why this needs to be a provider conversation, not a scale-only decision." HermanRX Clinical Care Team

That doesn't automatically make tirzepatide the "stronger" or "better" choice for every patient. Some people respond very well to a GLP-1-only medication, value the stronger cardiovascular evidence, or prefer the lower monthly cost of semaglutide. Others who have plateaued on semaglutide, or who want the added GIP effect, often do better switching to tirzepatide. This is exactly the kind of decision a licensed provider is trained to help you make after reviewing your history, not something to self-select from a product page.

How Dosing Works (Titration)

Both medications are started at a low dose and increased gradually, typically every four weeks, under provider guidance. This step-up approach, called titration, gives your body time to adjust. It's the single biggest factor in minimising nausea and GI discomfort. Skipping ahead to a higher dose too quickly is one of the most common reasons patients experience stronger side effects. Dose changes should always be made with your provider's input, not on your own.

Side Effects: Semaglutide vs. Tirzepatide

Both medications share a similar side effect profile because they work on overlapping digestive-system pathways. The most commonly reported effects include:

• Nausea, especially in the first few weeks or after a dose increase

• Diarrhoea or constipation

• Reduced appetite and early fullness

• Mild fatigue or headache

Does Tirzepatide Cause More Side Effects?

Tirzepatide's dual mechanism can make gastrointestinal side effects feel slightly more noticeable for some patients during the initial titration phase, though this varies from person to person. Some preclinical research suggests GIP receptor activity may help attenuate GLP-1-related nausea. That benefit hasn't been consistently demonstrated in human clinical trials, though, so it shouldn't be assumed as a given.

What About "Ozempic Face"?

Rapid or significant weight loss on either medication can also change facial fat volume, sometimes referred to informally as "Ozempic face." This isn't a medication-specific side effect. It's a normal consequence of losing weight quickly by any method, and it's worth mentioning to your provider if it's a concern.

Starting at a low dose and increasing gradually, staying hydrated, and eating smaller, protein-forward meals all help minimise discomfort with either medication. Serious reactions are uncommon but possible, which is why ongoing follow-up with your care team matters throughout treatment.

What Happens If You Stop Treatment?

Weight regain after stopping GLP-1 treatment is common and well-documented. In an extension of the original STEP 1 trial, participants who discontinued semaglutide regained roughly two-thirds of their lost weight within a year. This is one reason providers often frame GLP-1 treatment as a longer-term plan rather than a short course. Ongoing clinical support, not just the prescription itself, matters for maintaining results.

Cost Comparison

Compounded vs. Brand-Name Medications

Which GLP-1 Is Best for You?

There's no universal answer to which GLP-1 is best for weight loss. "Best" depends on your BMI, medical history, prior treatment response, tolerance for side effects, and budget. A general starting framework looks like this:

• Consider semaglutide if you're newer to GLP-1 treatment, want the option with the stronger cardiovascular data, or prefer the lower monthly price.

• Consider tirzepatide if you have more weight to lose, have plateaued on semaglutide before, or your provider identifies GIP activity as a good fit for your metabolic profile.

Either way, this is a decision made with a licensed provider, not a quiz result or a product card. That's the model HermanRX is built around.

Availability, Insurance & Payment

HermanRX operates on a transparent cash-pay model, so no insurance is required for either treatment. HSA and FSA cards can be used at checkout for eligible telehealth expenses, just like a standard debit card. Treatment is available in most U.S. states; a licensed provider will confirm availability and eligibility for your location during your assessment.

How to Get Started

Getting started looks the same for both medications. Complete a short online health assessment and have it reviewed by a licensed provider within about 24 hours. If treatment is appropriate, your medication ships discreetly. You can compare both options side by side and start your online weight-loss assessment to find out which one your provider recommends for your goals.

Frequently Asked Questions

Is tirzepatide always better than semaglutide?

Not necessarily. Tirzepatide tends to produce greater average weight loss in clinical trials, but semaglutide has stronger long-term cardiovascular outcome data. "Better" depends on your individual response, health priorities, tolerance for side effects, and cost preference. A licensed provider evaluates your specific situation rather than defaulting to whichever medication performs better on one measure.

Can I switch from semaglutide to tirzepatide later?

Many patients start on one medication and switch to the other if they plateau or want a different approach. Any switch should be guided by your provider, who can adjust dosing and monitor the transition.

Are compounded semaglutide and tirzepatide safe?

Compounded medications are prepared by licensed pharmacies for individual patients after a provider determines they're appropriate. They are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. It's important to work with a provider who can explain what you're being prescribed and monitor you throughout treatment.

What is "Ozempic face" and does it happen with these medications?

"Ozempic face" refers to a gaunter facial appearance that can occur with any rapid or significant weight loss, not just with semaglutide specifically. It results from reduced facial fat volume rather than a unique drug effect. It's a reasonable topic to raise with your provider if you're concerned about it.

How quickly will I see results?

Most patients begin noticing appetite changes within the first few weeks. More visible weight loss typically builds over several months as the dose is titrated up. Results vary by individual, dose, and adherence to the treatment plan.

Do I need insurance to start treatment?

No. HermanRX operates on a cash-pay model, so no insurance is required for either Semaglutide + B12 or Tirzepatide + B12, and HSA/FSA cards are accepted at checkout.

The Bottom Line

Semaglutide and tirzepatide are both effective, physician-prescribed tools for weight loss. The difference between them comes down to mechanism, average results, cardiovascular data, and cost, not one being universally "better." The most reliable way to decide is a real assessment with a licensed provider who can weigh your history against both options. Compare Semaglutide + B12 and Tirzepatide + B12 and start your online visit to find out which treatment fits you.